Literature DB >> 19888725

Structural properties of pore-forming oligomers of alpha-synuclein.

Hai-Young Kim1, Min-Kyu Cho, Ashutosh Kumar, Elke Maier, Carsten Siebenhaar, Stefan Becker, Claudio O Fernandez, Hilal A Lashuel, Roland Benz, Adam Lange, Markus Zweckstetter.   

Abstract

Soluble oligomers are potent toxins in many neurodegenerative diseases, but little is known about the structure of soluble oligomers and their structure-toxicity relationship. Here we prepared on-pathway oligomers of the 140-residue protein alpha-synuclein, a key player in Parkinson's disease, at concentrations an order of magnitude higher than previously possible. The oligomers form ion channels with well-defined conductance states in a variety of membranes, and their beta-structure differs from that of amyloid fibrils of alpha-synuclein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888725     DOI: 10.1021/ja9077599

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  71 in total

1.  Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation.

Authors:  Jonathan A Fauerbach; Dmytro A Yushchenko; Sarah H Shahmoradian; Wah Chiu; Thomas M Jovin; Elizabeth A Jares-Erijman
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state.

Authors:  Tobias Högen; Johannes Levin; Felix Schmidt; Mario Caruana; Neville Vassallo; Hans Kretzschmar; Kai Bötzel; Frits Kamp; Armin Giese
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

3.  A soluble α-synuclein construct forms a dynamic tetramer.

Authors:  Wei Wang; Iva Perovic; Johnathan Chittuluru; Alice Kaganovich; Linh T T Nguyen; Jingling Liao; Jared R Auclair; Derrick Johnson; Anuradha Landeru; Alana K Simorellis; Shulin Ju; Mark R Cookson; Francisco J Asturias; Jeffrey N Agar; Brian N Webb; Chulhee Kang; Dagmar Ringe; Gregory A Petsko; Thomas C Pochapsky; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

4.  Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.

Authors:  Edward F Griffin; Xiaohui Yan; Kim A Caldwell; Guy A Caldwell
Journal:  Hum Mol Genet       Date:  2018-12-15       Impact factor: 6.150

5.  Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein.

Authors:  Santiago Esteban-Martín; Jordi Silvestre-Ryan; Carlos W Bertoncini; Xavier Salvatella
Journal:  Biophys J       Date:  2013-09-03       Impact factor: 4.033

6.  α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.

Authors:  Dorit Trudler; Sara Sanz-Blasco; Yvonne S Eisele; Swagata Ghatak; Karthik Bodhinathan; Mohd Waseem Akhtar; William P Lynch; Juan C Piña-Crespo; Maria Talantova; Jeffery W Kelly; Stuart A Lipton
Journal:  J Neurosci       Date:  2021-01-22       Impact factor: 6.167

Review 7.  Biophysics of α-synuclein membrane interactions.

Authors:  Candace M Pfefferkorn; Zhiping Jiang; Jennifer C Lee
Journal:  Biochim Biophys Acta       Date:  2011-07-28

8.  Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein.

Authors:  Min-Kyu Cho; Hai-Young Kim; Claudio O Fernandez; Stefan Becker; Markus Zweckstetter
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

Review 9.  Exploring the accessible conformations of N-terminal acetylated α-synuclein.

Authors:  Gina M Moriarty; Maria K Janowska; Lijuan Kang; Jean Baum
Journal:  FEBS Lett       Date:  2013-03-13       Impact factor: 4.124

10.  Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation.

Authors:  Guiping Du; Xiang Liu; Xinping Chen; Mei Song; Yan Yan; Renjie Jiao; Chih-Chen Wang
Journal:  Mol Biol Cell       Date:  2010-05-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.